Investor disclosure. That the trial is on hold is material information to investors but the medical reasons why it’s in hold (like the type of adverse reactions

Investor disclosure. That the trial is on hold is material information to investors but the medical reasons why it’s in hold (like the type of adverse reactions) probably isn’t.